- Previous Close
203.00 - Open
204.00 - Bid 202.50 x 391200
- Ask 203.00 x 721000
- Day's Range
202.00 - 204.00 - 52 Week Range
149.20 - 209.50 - Volume
4,816 - Avg. Volume
62,414 - Market Cap (intraday)
20.199B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
25.31 - EPS (TTM)
8.00 - Earnings Date Oct 30, 2024
- Forward Dividend & Yield 3.75 (1.85%)
- Ex-Dividend Date Apr 12, 2024
- 1y Target Est
215.50
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and advanced bioethanol products. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
www.borregaard.com1,127
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BRG.OL
View MorePerformance Overview: BRG.OL
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRG.OL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRG.OL
View MoreValuation Measures
Market Cap
20.25B
Enterprise Value
22.42B
Trailing P/E
25.38
Forward P/E
16.47
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.84
Price/Book (mrq)
4.13
Enterprise Value/Revenue
3.14
Enterprise Value/EBITDA
12.70
Financial Highlights
Profitability and Income Statement
Profit Margin
11.04%
Return on Assets (ttm)
8.61%
Return on Equity (ttm)
17.44%
Revenue (ttm)
7.24B
Net Income Avi to Common (ttm)
800M
Diluted EPS (ttm)
8.00
Balance Sheet and Cash Flow
Total Cash (mrq)
311M
Total Debt/Equity (mrq)
50.17%
Levered Free Cash Flow (ttm)
387.75M